Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

05:00 ET PharmAkea Announces Successful Completion of a Phase 1 Trial in Healthy Subjects For Its Novel LOXL2 Inhibitor, PAT-1251

PharmAkea, Inc. announced that it has successfully completed a Phase 1 single and multiple ascending dose (SAD/MAD) clinical study with PAT-1251,...


03:00 ET Finalists Announced for 2017 LogiPharma Supply Chain Awards

Industry awards celebrating projects and teams that have transformed supply chains in pharmaceutical companies....


03:00 ET Presentati a ESC i nuovi e importanti dati del registro GARFIELD AF, che descrivono i risultati a un anno su 52.000 pazienti prospettici e mostrano i primi elementi economico-sanitari sul tema della FA(AF) FA(AF)

- Saranno discussi i tassi di embolismo sistemico/ictus e di emorragia grave a un anno in tutte e cinque le coorti, oltre all'impatto...


03:00 ET Landmark GARFIELD-AF Data to be Presented at ESC 2017 Congress Will Feature 1-year Outcomes on 52,000 Prospective Patients and the First Insights From the Registry on Health Economics in Atrial Fibrillation (AF)

- One-year stroke/systemic embolism and major bleeding rates for all five cohorts will be discussed, as well as the impact of comorbidities...


Aug 21, 2017, 22:00 ET First Patient Dosed in Phase 3 MORPHO Trial Evaluating Gilteritinib as Maintenance Therapy Following Hematopoietic Stem Cell Transplant in Patients with FLT3 Mutation-positive Acute Myeloid Leukemia

Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") announced today that the first patient was dosed in the...


Aug 21, 2017, 17:22 ET Sorrento Contributes To The Formation Of Celularity, Inc. For Breakthrough Placental Therapeutic Platform In Consortium With Leading Pharmaceutical Companies

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced that the transactions contemplated by the Contribution Agreement it entered with...


Aug 21, 2017, 16:30 ET Novartis launches first large-scale research study in multiple sclerosis that allows participants to contribute from smartphones

Novartis announced today the launch of a mobile research study for people with multiple sclerosis (MS) that collects data via their smartphone,...


Aug 21, 2017, 16:15 ET Axovant to Move Stock Exchange Listing to Nasdaq

Axovant Sciences (NYSE: AXON) today announced that it will voluntarily move its stock exchange listing from the New York Stock Exchange to the...


Aug 21, 2017, 16:15 ET Intec Pharma Announces Closing of $57.5 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the closing of its previously announced offering of approximately 12.2 million of its...


Aug 21, 2017, 15:34 ET Uptake of Sanofi/Regeneron's Dupixent for Atopic Dermatitis Strong, but Sales Representative Contact Rates Leave Something to be Desired

According to the Q3 update of RealTime Dynamix™: Atopic Dermatitis, US dermatologists (n=104) continue to show strong adoption of Dupixent...


Aug 21, 2017, 12:20 ET Global Health Solutions Partners with Camargo Pharmaceutical Services for Onychomycosis Development Program

Global Health Solutions, LLC ("Global Health Solutions"), a Georgia based biotechnology company developing next-generation therapies for wound...


Aug 21, 2017, 10:47 ET Statement from FDA Commissioner Scott Gottlieb, M.D. - FDA is carefully evaluating prescription opioid medications approved to treat cough in children

There's perhaps no more important mandate that we have at the FDA than safeguarding the health and safety of children. For that reason, I believe...


Aug 21, 2017, 10:30 ET Systech International Showcases Innovative Serialization and Authentication Solutions at Institute of Packaging Professionals (IOPP) - Puerto Rico Chapter Conference

Systech International, the pioneer in pharmaceutical serialization technology and leader in brand protection software, is proud to feature its...


Aug 21, 2017, 10:15 ET International Isotopes Inc. Announces It Has Assumed Management of RadQual, LLC

International Isotopes Inc. (OTCQB: INIS) (the "Company" or "INIS") announced that a group of buyers has acquired all the units of RadQual, LLC...


Aug 21, 2017, 09:15 ET Pneumonia Therapeutics Market Analysis 2014 - 2025

The "Pneumonia Therapeutics Market Analysis By Product (Drugs, Branded, Quinolones, Aminopenicillins, Macrolides, B-lactamase Inhibitors,...


Aug 21, 2017, 09:00 ET Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has received final approval from the U.S. Food & Drug Administration for the...


Aug 21, 2017, 09:00 ET Amgen To Present New Data From The Repatha® (Evolocumab) Cardiovascular Outcomes Study At ESC Congress 2017

Amgen (NASDAQ:AMGN) today announced that new data from the Repatha® (evolocumab) clinical trial program, including three late-breaking scientific...


Aug 21, 2017, 09:00 ET Upsher-Smith Launches Newly Designed Website For Qudexy® XR (topiramate) Extended-Release Capsules

Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the launch of its enhanced website for Qudexy® XR (topiramate) Extended-Release...


Aug 21, 2017, 08:30 ET Forbes Ranks BioMarin 12th Most Innovative Company in the World

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that it has been ranked 12th on Forbes magazine's 2017 list of the "World's Most...


Aug 21, 2017, 08:00 ET Marapharm Ventures Inc. "Marapharm" Schedules Completion Date for Buildings in Las Vegas, Nevada

Marapharm Ventures Inc. (OTCQB: MRPHF) (CSE: MDM.CN) (FSE: 2M0) ("Marapharm" or the " Company") (http://www.marapharm.com/) announces that two...


Aug 21, 2017, 08:00 ET Trovagene's PLK1 Inhibitor PCM-075 Demonstrates Synergy with a HDAC Inhibitor in Non-Hodgkin Lymphoma Cell Lines

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced compelling results of preclinical research of PCM-075...


Aug 21, 2017, 08:00 ET New XARELTO® (rivaroxaban) Data at ESC Congress 2017 Includes Late-Breaking Results from Landmark Phase 3 COMPASS Study

New data from the landmark Phase 3 COMPASS study evaluating the use of XARELTO® (rivaroxaban) in coronary and peripheral artery disease (CAD and...


Aug 21, 2017, 07:02 ET Cellect Biotechnology Ltd Provides Corporate Update and Reports Second Quarter 2017 Financial Results

Cellect Biotechnology Ltd. (NASDAQ: APOP, TASE: APOP), a developer of innovative technology which enables the functional selection of stem cells,...